16
Mar
2016

Sanofi Bets $50M on DiCE, a Directed Evolution Twist on Drug Discovery

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $149 per year, you reward quality independent biotech reporting, and encourage more.

You may also like

When Does it Make Sense to Acqui-Hire in Biotech?